EXPRESS ZERTIFIKAT - FRESENIUS Stock

Certificat

XS1273324365

Market Closed - Deutsche Boerse AG 10:54:55 2024-05-24 am EDT
614.9 EUR +4.26% Intraday chart for EXPRESS ZERTIFIKAT - FRESENIUS
Current month+4.38%
1 month+7.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 614.9 +4.26%
24-05-23 589.8 +2.31%
24-05-22 576.4 +0.67%
24-05-21 572.6 -0.97%
24-05-20 578.2 -0.55%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 10:54 am EDT

More quotes

Static data

Product typeCertificats Divers
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Citi Citi
WKN A27621
ISINXS1273324365
Date issued 2020-02-28
Strike 37.24
Maturity 2025-02-21 (271 Days)
Parity 0.04 : 1
Emission price 1,000
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 1,055
Lowest since issue 386.7

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.93 EUR
Average target price
36.72 EUR
Spread / Average Target
+26.94%
Consensus